Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Interventional × Ringer's Lactate × Clear all

Phase

Status

Completed 5 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hearing Loss 1 Ear Neoplasms 1

Interventions

Cyclophosphamide 99 Cisplatin 97 Radiotherapy 95 pembrolizumab 90 Paclitaxel 74 Carboplatin 72 Nivolumab 67 Gemcitabine 67 Fluorouracil 63 Magnetic Resonance Spectroscopy 62 Dexamethasone 57 Bevacizumab 56 Radiosurgery 52 Docetaxel 51 Rituximab 48 Oxaliplatin 47 Leucovorin 47 fludarabine 44 Capecitabine 44 Biopsy 39 Doxorubicin 37 durvalumab 34 Etoposide 34 Drug Therapy 34 Cytarabine 34 Radiation 33 fludarabine phosphate 32 Pemetrexed 32 Lenalidomide 32 Irinotecan 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00584155 2015-05-27

Protection From Cisplatin Ototoxicity by Lactated Ringers

University of Oklahoma

Phase 1 Withdrawn

Ear Neoplasms, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡